Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor vasculature: a sally port for inhibiting cancer cell spreading
Chao‐Nan Qian, Francesco Pezzella
Cancer Communications (2018) Vol. 38, Iss. 1, pp. 1-3
Open Access | Times Cited: 21

Showing 21 citing articles:

Vasculogenic mimicry in carcinogenesis and clinical applications
Qingxi Luo, Jun Wang, Wenyuan Zhao, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 232
Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
Yudong Su, Bingying Luo, Yao Lu, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 4, pp. 793-809
Open Access | Times Cited: 90
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
Yadi Liao, Chenwei Wang, Zhiwen Yang, et al.
Theranostics (2020) Vol. 10, Iss. 12, pp. 5209-5224
Open Access | Times Cited: 80
Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma
Ning Zheng, Shaoqin Zhang, Wenda Wu, et al.
Pharmacological Research (2021) Vol. 166, pp. 105507-105507
Closed Access | Times Cited: 45
Oncolytic Virotherapy: From Bench to Bedside
Ludi Yang, Xiang Gu, Jie Yu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography
Chenchen Liu, Xiaoming Liu, Zhihao Wei, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 8, pp. 9702-9712
Closed Access | Times Cited: 6
Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer
Jing Zhong, Yan Tang
Progress in Biophysics and Molecular Biology (2024) Vol. 188, pp. 1-18
Closed Access | Times Cited: 5
ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma
Ying Shi, Jin Shang, Yan Li, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3786-3796
Open Access | Times Cited: 18
Methotrexate-modified docetaxel liposome targeting with ginsenoside Rh2 as a membrane stabilizer for the treatment of ovarian cancer
Mo Liu, Shutong Li, Jiahua Wang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 98, pp. 105917-105917
Closed Access | Times Cited: 2
The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy
Charlotte W. Duinkerken, Sabrina Chiodo, Katrina Hueniken, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 2
Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line
Sara Peri, Alessio Biagioni, Giampaolo Versienti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7698-7698
Open Access | Times Cited: 15
Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
Qingbo Li, Patrick Kwabena Oduro, Rui Guo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 9
The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice
Lu Zhang, Liang Kong, Siyu He, et al.
Life Sciences (2021) Vol. 285, pp. 120013-120013
Closed Access | Times Cited: 10
Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells
Yujia Wang, Ling Tang, Xuhong Lu, et al.
Journal of Liposome Research (2022) Vol. 33, Iss. 2, pp. 197-213
Closed Access | Times Cited: 6
Oncolytic Virotherapy
Munazza Fatima, Deeba Amraiz, Muhammad Tariq Navid
Cancer treatment and research (2023), pp. 105-126
Closed Access | Times Cited: 2
Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations
Maryam Saqib, Zari Salahuddin, Sehrish Zaffar, et al.
Personalized Medicine (2024), pp. 1-16
Closed Access
Issues of origin, morphology and clinical significance of tumor microvessels in gastric cancer
M. A. Senchukova
World Journal of Gastroenterology (2021) Vol. 27, Iss. 48, pp. 8262-8282
Open Access | Times Cited: 3
Data from Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
Yudong Su, Bingying Luo, Yao Lu, et al.
(2023)
Open Access
Pan-cancer analysis reveals the relationship between SLC47A1 immune infiltration and clinical prognosis of human tumors
Nan Huang, Zheng LIU, Ronghui Li
Journal of Holistic Integrative Pharmacy (2023) Vol. 4, Iss. 1, pp. 103-118
Open Access
Factors Affecting Peroperative Bleeding Amount and Need for Blood Transfusion in Retropubic Radical Prostatectomy Operation
Osman Gerçek, Veli Mert Yazar, Murat Ati̇k, et al.
OSMANGAZİ JOURNAL OF MEDICINE (2023) Vol. 45, Iss. 6
Open Access
Origen, morfología y significancia clínica de microvesículas de tumor en cáncer gástrico
M. A. Senchukova
Magna Scientia UCEVA (2022) Vol. 2, Iss. 1, pp. 5-25
Open Access
Page 1

Scroll to top